You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasma Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Plasma Cell Leukemia in Relapse
  • Biological
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital
May 29, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

Not yet recruiting
  • Multiple Myeloma
  • Primary Plasma Cell Leukemia
  • Experimental: CAR-T cells Infusion
  • Shanghai, China
    Shanghai Changzheng Hospital
Apr 20, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Plasma Cell Leukemia
  • CAR-T (CAR-GPRC5D)
  • (no location specified)
Feb 26, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023

Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

Recruiting
  • Endometrial Cancer
  • low-depth whole-genome sequencing technology
  • Guangzhou, Guangdong, China
    The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 9, 2023

RRMM, Other Plasma Cell Diseases Trial (LM-305, Dexamethasone)

Not yet recruiting
  • RRMM
  • Other Plasma Cell Diseases
  • (no location specified)
Dec 1, 2022

Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

Recruiting
  • Ovarian Cancer
    • Guangzhou, Guangdong, China
      The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Jan 12, 2023

    Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

    Active, not recruiting
    • Ovarian Cancer
      • Guangzhou, Guangdong, China
        The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Jan 12, 2023

      Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Wuhan, Hubei, China
        Institute of Hematology, Union Hospital, Tongji Medical College,
      Nov 18, 2023

      Multiple Myeloma Trial in Wuhan (SENL103)

      Recruiting
      • Multiple Myeloma
      • SENL103
      • Wuhan, Hubei, China
        Tongji Hospital
      Sep 27, 2023

      Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Plasma Cell Leukemia
      • CAR-T (CAR-GPRC5D)
      • Wuhan, Hu Bei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      May 17, 2022

      Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

      Completed
      Has Results
      • Myelodysplastic Syndrome
      • +13 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Nov 2, 2022

      Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

      Not yet recruiting
      • Leukemia, Acute
      • +7 more
      • (no location specified)
      Apr 10, 2023

      A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

      Recruiting
      • Multiple Myeloma
      • +11 more
      • No intervention
      • Beijing, China
        Peking University First Hospital
      Apr 21, 2022

      Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

      Active, not recruiting
      Has Results
      • Plasma Cell Leukemia
      • +2 more
      • Rochester, Minnesota
      • +1 more
      May 19, 2022

      Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

      Active, not recruiting
      • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
      • Plasma Cell Myeloma
      • Incomplete Freund's Adjuvant
      • +4 more
      • Buffalo, New York
      • +1 more
      Dec 12, 2022

      Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

      Recruiting
      • Plasma Cell Myeloma
      • Biospecimen Collection
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jun 26, 2023

      Management of Plasma Cell Gingivitis by Two Surgical Techniques

      Completed
      • Plasma Cell Gingivitis
      • soft tissue laser
      • Cairo, Egypt
        Ain shams University
      Feb 2, 2022

      Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

      Active, not recruiting
      • Plasma Cell Leukemia
      • +3 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 6, 2022

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

      Recruiting
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Jan 24, 2023

      Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Radiation Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 9, 2022

      Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

      Recruiting
      • Plasma Cell Myeloma
      • +3 more
      • Bone Marrow Biopsy
      • +3 more
      • Phoenix, Arizona
      • +2 more
      Jan 18, 2023